Recursion Pharmaceuticals Correlations

RXRX Stock  USD 7.10  0.15  2.16%   
The current 90-days correlation between Recursion Pharmaceuticals and Relay Therapeutics is -0.12 (i.e., Good diversification). The correlation of Recursion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Recursion Pharmaceuticals Correlation With Market

Good diversification

The correlation between Recursion Pharmaceuticals and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Recursion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Recursion Stock please use our How to Invest in Recursion Pharmaceuticals guide.

Moving against Recursion Stock

  0.35JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.33ALVO AlvotechPairCorr
  0.38AQST Aquestive TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RLAYSANA
RLAYAFMD
CNSPRLAY
SANAABSI
RLAYABSI
SANAAFMD
  
High negative correlations   
AVROSANA
AVRORLAY
AVROABSI
AVROAFMD
IMMXSANA
IMMXAFMD

Risk-Adjusted Indicators

There is a big difference between Recursion Stock performing well and Recursion Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Recursion Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ABSI  4.15  0.21  0.02 (0.34) 5.77 
 8.29 
 41.22 
AFMD  2.64 (0.98) 0.00 (0.62) 0.00 
 7.25 
 24.94 
SANA  4.17 (1.11) 0.00  1.47  0.00 
 9.02 
 28.04 
RLAY  2.75 (0.80) 0.00 (0.28) 0.00 
 5.04 
 16.43 
IMMX  4.84  0.35  0.06  0.84  5.23 
 11.44 
 35.42 
CNSP  4.62 (0.45) 0.00 (0.47) 0.00 
 10.00 
 39.29 
HEPA  3.74 (0.46) 0.00 (0.34) 0.00 
 8.06 
 33.54 
FRLN  5.90 (0.36) 0.00 (0.03) 0.00 
 14.23 
 72.38 
AVRO  1.77  0.16  0.03 (0.63) 1.89 
 4.11 
 14.20 
EFTR  7.57 (4.81) 0.00 (1.39) 0.00 
 8.70 
 88.91 

Recursion Pharmaceuticals Corporate Management

Christopher GibsonCEO CoFounderProfile
Kevin LeggatVice AccountingProfile
Janelle GordonVice OperationsProfile
Shafique MDInterim OfficerProfile
Nathan HatfieldChief OfficerProfile